ADR,SEQ,ROUTE,MULTICONST,NONSERIOUS_SERIOUS_FATAL_NSF
1,1,SUBCUTANEOUS USE,N,N
2,1,SUBCUTANEOUS USE,N,N
3,1,SUBCUTANEOUS USE,N,N
4,1,SUBCUTANEOUS USE,N,S
5,1,UNKNOWN,N,F
6,1,UNKNOWN,N,S
7,1,SUBCUTANEOUS USE,N,F
7,2,SUBCUTANEOUS USE,N,F
8,1,UNKNOWN,N,F
8,2,UNKNOWN,N,F
9,1,SUBCUTANEOUS USE,N,S
10,1,UNKNOWN,N,N
11,1,UNKNOWN,N,S
12,1,UNKNOWN,N,F
13,1,UNKNOWN,N,F
13,2,UNKNOWN,N,F
14,1,UNKNOWN,N,F
15,1,UNKNOWN,N,F
15,2,UNKNOWN,N,F
16,1,UNKNOWN,N,N
17,1,UNKNOWN,N,N
18,1,UNKNOWN,N,S
19,1,UNKNOWN,N,F
20,1,UNKNOWN,N,S
21,1,UNKNOWN,N,N
22,1,UNKNOWN,N,N
23,1,SUBCUTANEOUS USE,N,S
